Results 81 to 90 of about 96,172 (145)

Advances in Pharmacotherapy and Physiotherapy for Dry Eye Disease: Molecular Mechanisms and Future Directions-A Narrative Literature Review. [PDF]

Int J Mol Sci
Liu J, Zheng H, Shi J, Hao M, Yang Q, Luo H, Zhang X.   +6 more
europepmc   +1 more source

"Acoltremon: a novel advancement in dry eye disease management". [PDF]

Ann Med Surg (Lond)
Khalid M, Zahid E, Shaheer M.
europepmc   +1 more source

Impact of Time of Day on Dry Eye Disease: Findings from a Large Dry Eye Clinic Cohort. [PDF]

Clin Ophthalmol
Bair JA, Khan AZ, Yazdani M, Ræder S, Utheim TP, Fineide FA.   +5 more
europepmc   +1 more source

Phosphosulindac (OXT-328) restores the suppressed corneal sensitivity in rabbits with dry eye disease: therapeutic implications. [PDF]

Front Drug Deliv
Huang W, Wen Z, Tourmouzis K, Huang L, Goldstein SM, Natke E, Honkanen R, Rigas B.   +7 more
europepmc   +1 more source

Efficacy and safety of pilocarpine as a secretagogue versus artificial tears in the management of dry eye disease. [PDF]

Med Hypothesis Discov Innov Ophthalmol
Elsayed Saad EM, Elbadry Mohammed Mohammed H, Tharwat E, Ali Ayoub AA, Salama Selim OH, Elsayed Abdelhafeez SM, Mohammed Yusef N, Farouk Soltan TA, Abdelhamid Elfar AA, Abdelhalim Ali Ali M.   +9 more
europepmc   +1 more source

Marine-Derived Neoagarotetraose Alleviates Dry Eye Disease by Suppressing Inflammation and Apoptosis in a Murine Model. [PDF]

Mar Drugs
Wu N, Du Y, Wu C, Chan Z, Zeng R.
europepmc   +1 more source

Efficacy and safety of stem cell therapy for dry eye disease: a systematic review and meta-analysis. [PDF]

Stem Cell Res Ther
Chen KY, Chan HC, Chan CM.
europepmc   +1 more source

Evaluating Dry Eye Disease Subtypes Based on Whole-Area Lipid Layer Thickness Assessment. [PDF]

J Clin Med
Ahn H, Choi YJ, Jun I, Kim TI, Seo KY.
europepmc   +1 more source

Dry Eye Disease: Bridging Systemic Inflammation, Ocular Surface Biology, and Clinical Innovation. [PDF]

Biomedicines
Gantz L.
europepmc   +1 more source